African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 772–779

DOI: 10.46882/AJIDR/149014

Article Type: Research Article

Title: Genomic surveillance and ceftazidime-avibactam susceptibility of KPC-producing Enterobacter cloacae complex in intensive care units

Names of Authors: Kemi Adewale¹*, Bjorn Lindqvist², Sanjay Kulkarni³

Abstract: Carbapenem-resistant Enterobacter cloacae complex has emerged as an important nosocomial pathogen capable of causing severe bloodstream and device-related infections. We investigated carbapenemase genotypes, outer membrane porin alterations, and novel beta-lactamase inhibitor susceptibility among clinical intensive care isolates. Blood and respiratory cultures from 132 hospitalized adults were analyzed via multiplex polymerase chain reaction, broth microdilution, and whole-genome sequencing. BlaKPC-2 and blaKPC-3 genes predominated in 68.2 percent of carbapenem-resistant isolates, while ceftazidime-avibactam retained 93.9 percent in vitro activity. Targeted antimicrobial stewardship and contact isolation curtail hospital transmission.

Keywords: Enterobacter cloacae, Carbapenemase, Ceftazidime-avibactam, Intensive care infection, Antimicrobial resistance

Citation: Adewale K, Lindqvist B, Kulkarni S (2026). Genomic surveillance and ceftazidime-avibactam susceptibility of KPC-producing Enterobacter cloacae complex in intensive care units. African Journal of Infectious Diseases Research, 13(11): 772–779. DOI: 10.46882/AJIDR/149014

Manuscript Timeline: Received: September 05, 2026; Revised: October 06, 2026; Accepted: November 02, 2026; Published: November 07, 2026